E. coli has long been widely used as a host system for the manufacture of recombinant proteins intended for human therapeutic use. When considering the impurities to be eliminated during the downstream process, residual host cell DNA is a major safety concern. The presence of residual E. coli host cell DNA in the final products is typically determined using a conventional slot blot hybridization assay or total DNA Threshold assay. However, both the former and latter methods are time consuming, expensive, and relatively insensitive. This study thus attempted to develop a more sensitive real-time PCR assay for the specific detection of residual E. coli DNA. This novel method was then compared with the slot blot hybridization assay and total DNA Threshold assay in order to determine its effectiveness and overall capabilities. The novel approach involved the selection of a specific primer pair for amplification of the E. coli 16S rRNA gene in an effort to improve sensitivity, whereas the E. coli host cell DNA quantification took place through the use of SYBR Green I. The detection limit of the real-time PCR assay, under these optimized conditions, was calculated to be 0.042 pg genomic DNA, which was much higher than those of both the slot blot hybridization assay and total DNA Threshold assay, where the detection limits were 2.42 and 3.73 pg genomic DNA, respectively. Hence, the real-time PCR assay can be said to be more reproducible, more accurate, and more precise than either the slot blot hybridization assay or total DNA Threshold assay. The real-time PCR assay may thus be a promising new tool for the quantitative detection and clearance validation of residual E. coli host cell DNA during the manufacturing process for recombinant therapeutics.
Among the many systems available for heterologous protein production, the Gram-negative bacterium E. coli remains one of the most attractive because of its ability to grow rapidly with a high density on inexpensive substrates, its well-characterized genetics, and the availability of an increasingly large number of cloning vectors and mutant host strains [1, 8, 20] .
The use of E. coli as the host for recombinant therapeutic proteins is subject to many regulatory issues, one of which is the clearance of the host cell DNA [3, 5, 18] . Although the significance of DNA-based contaminants in biopharmaceutical products remains unclear, there is a possibility that residual host cell DNA could transmit genetic information to patients receiving the products. Theoretically, entry of contaminant DNA into the genome of recipient cells could have serious clinical implications. These associated risks include the alteration of the level of expression of cellular genes, or the expression of a foreign gene product [22] . As a consequence, the regulatory authorities state that manufacturers of biopharmaceuticals should control and quantify the amount of residual host cell DNA in final products and validate the clearance of residual host cell DNA during the downstream process. The acceptable residual amount of DNA in the U.S.A., as specified in the Food and Drug Administration (FDA) guidelines, is 100 pg per dose, utilizing testing procedures that can detect 10 pg [5] . The limit permitted by the World Health Organization (WHO) and the European Union (EU) is up to 10 ng per dose [4] .
For a number of years, the species-specific DNA hybridization assay and the total DNA Threshold assay have been used to quantify the amount of residual host cell DNA in biopharmaceuticals [26] . The basic principle of a hybridization assay is based on the binding of the DNA probe to immobilized and denatured host cell DNA. The concentration of hybridized DNA in the test sample is evaluated by comparing the hybridization signal generated by the test sample with that of the control standard. The *Corresponding author Phone: +82-42-629-8754; Fax: +82-42-629-8751; E-mail: inskim@hnu.kr total DNA Threshold assay is primarily based on the sequence-independent binding of two proteins specific to single-stranded DNA (ssDNA) [11] . In the latter, one binding protein acts as an antibody, and the other as a socalled single-stranded DNA binding (SSB) protein. First, a reaction complex is formed when the biotinylated SSB protein and the anti-ssDNA antibody (conjugated to urease) bind to single-stranded host cell DNA. A filtration stage follows, during which the strong affinity of streptavidin for biotin is utilized to capture and concentrate the reaction complex onto a biotinylated membrane. For detection, the membrane is placed into a reader that contains the substrate urea. Inside, the urea is hydrolyzed by urease to produce a pH change, which is relative to the amount of host cell DNA in the sample.
In the biopharmaceuticals industry, real-time PCR has been applied to amplify and simultaneously quantify a targeted DNA molecule. This enables both the detection and the quantification of a specific sequence in a DNA sample. Practically, real-time PCR has been used to characterize and detect numerous bacterial, fungal, and viral loads in protein therapeutics [9, 10, 13, 16, 24, 25] . Applications of real-time PCR for the specific detection of residual E. coli host cell DNA in plasmid preparations have also been reported [15, 21] . However, in the latter examples, the sensitivity of the assays was found to be at the 1 pg level, which is nearly the same as those of the slot blot hybridization assay and the total DNA Threshold assay. Recently, a real-time PCR based on SYBR chemistry was developed to specifically and quantitatively detect residual Chinese hamster ovary (CHO) host cell DNA [17] . The real-time PCR method was in these cases found to be highly sensitive and specific. The method could detect CHO genomic DNA to 300 fg. This level of sensitivity is higher than those of both the DNA hybridization method and the total DNA Threshold assay.
The objective of this study is to develop a highly sensitive and specific detection method of E. coli host cell DNA using real-time PCR as an alternative means to the conventional slot blot hybridization assay and total DNA Threshold assay. In order to develop a convenient, rapid, and sensitive way of measuring the residual E. coli host cell DNA, a real-time PCR assay based on SYBR chemistry is proposed and will then be compared with the slot blot hybridization assay and the total DNA Threshold assay so as to validate the overall capability of these varying methods.
MATERIALS AND METHODS

Bacterial Strain and Culture Medium
The strain used in this study was E. coli KCTC 1102 harboring a plasmid pET 21b carrying the gene for the granulocyte colonystimulating factor (Novogen Ltd., U.S.A.). The E. coli strain was grown in LB medium containing 50 µg/ml of ampicillin at 37 o C.
Preparation of Genomic DNA Genomic DNA was extracted from E. coli using an SV mini kit (General Bio System Inc., Korea) in accordance with the manufacturer's instructions. DNA integrity and concentration were determined by spectrophotometric analysis at 260 nm and 280 nm (UV-1650 PC; Schimadzu Corp., Japan).
Primer Design and PCR Specificity Test
Oligonucleotide primers against the 16S rRNA gene (GenBank Accession No. J01859.1) were designed for the detection of E. coli DNA by real-time PCR using Primer3 [19] . The primers were synthesized by Bioneer Corp. (Korea). To determine the efficiency of the primers, genomic DNA extracted from E. coli was serially diluted 10-fold from 42,000 pg to 0.042 pg. A PCR reaction was then carried out with each primer pair using the templates of serially diluted genomic DNA. The PCR was performed in a Palm-Cycler (Corbett Research Ltd., Australia) using the following conditions: initial heat denaturation at 95 Determination of Sensitivity and Reproducibility of Real-Time PCR Assay To obtain a standard curve and to verify the sensitivity of the realtime PCR assay, serial 10-fold dilutions from 42,000 pg to 0.042 pg of E. coli genomic DNA, were amplified using the optimized conditions. A standard curve for quantification was generated by plotting the log of the DNA concentration of the known standard against the threshold cycle (Ct) value.
